Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carlisle

358.77
+0.28000.08%
Volume:117.64K
Turnover:42.13M
Market Cap:15.48B
PE:13.13
High:359.77
Open:358.07
Low:356.92
Close:358.49
Loading ...

Wilsons Sticks to Their Hold Rating for CSL (CMXHF)

TIPRANKS
·
12 Feb

CSL (CMXHF) Gets a Buy from Bell Potter

TIPRANKS
·
12 Feb

Flu Vaccines Proving Problematic for CSL -- Market Talk

Dow Jones
·
12 Feb

Everything you need to know about the latest CSL dividend

MotleyFool
·
12 Feb

What are brokers saying about CSL shares after the selloff?

MotleyFool
·
12 Feb

Is CSL undervalued after earnings season wobble?

Morning Star AU
·
12 Feb

Closing Bell: Gold hits record high, but CSL’s late sell-off drags ASX down

Stockheads
·
11 Feb

CSL falls short, despite $8.48 billion revenue

LiveWire
·
11 Feb

Australian Shares Flat as Trump Orders Tariffs; CSL Posts Higher Fiscal H1 Earnings

MT Newswires Live
·
11 Feb

CSL Limited Reports Growth Amid Strong Demand

TIPRANKS
·
11 Feb

CSL Limited Reports Strong Half-Year Financial Performance

TIPRANKS
·
11 Feb

Health Check: CSL’s blood business saves the day amid declining flu jab rates

Stockheads
·
11 Feb

Citi Reaffirms Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
11 Feb

Market Chatter: CSL Fiscal First-Half Results Misses Expectations, Barrenjoey Says

MT Newswires Live
·
11 Feb

CSL up 6% on strong demand for CSL Behring business

The Market Herald
·
11 Feb

CSL says on track for double-digit growth but vaccine sales weak

The Australian Financial Review
·
11 Feb

CSL Posts Higher Fiscal H1 Earnings, Revenue; Reaffirms Outlook

MT Newswires Live
·
11 Feb

CSL share price on watch amid $2.1b half year profit and dividend hike

MotleyFool
·
11 Feb

CSL Posts EPS of $4.13, Total Operating Revenue of $8.48 Billion in Half Year Ended Dec. 31, 2024

MT Newswires Live
·
11 Feb

CSL Lifts 1H Net Profit by 3%, Led by Blood-Plasma Business -- Update

Dow Jones
·
11 Feb